Home / Moved to Main Board / Indo US Bio-Tech
Indo US Bio-Tech: IPO, Share Price and Results Since Listing
Indo US Bio-Tech moved from BSE SME to the BSE main board. For Q2 FY2027 it reported revenue of INR 15.05 crore (-51.22% on a year earlier) and a loss of INR 3.67 crore.
Key Facts
- Moved to
- BSE main board (BSE does not publish the date)
- Listed on BSE SME
- 11 May 2018
- Symbol
- INDOUS (BSE code 541304)
- Latest close
- INR 66.10 on 13 November 2026
Results Filed With BSE
Standalone figures, INR crore. Change compares with the same period a year earlier.
| Period | Revenue | Change | Profit after tax | EPS (INR) | Filed | |
|---|---|---|---|---|---|---|
| Q2 FY2027 | 15.05 | -51.22% | -3.67 | -1.83 | after listing | 30 October 2026 |
| Q1 FY2027 | 32.99 | +7.21% | 3.04 | 1.51 | after listing | 12 August 2026 |
| Q4 FY2026 | 26.02 | -22.05% | 1.97 | 0.98 | after listing | 29 May 2026 |
| FY2026 | 110.44 | +6.36% | 13.12 | 6.54 | after listing | 29 May 2026 |
| Q3 FY2026 | 22.80 | – | 3 | 1.49 | after listing | 21 January 2026 |
| Q2 FY2026 | 30.85 | – | 3.45 | 1.72 | after listing | 29 November 2025 |
| Q1 FY2026 | 30.77 | – | 4.70 | 2.35 | after listing | 13 August 2025 |
| Q4 FY2025 | 33.38 | – | 3.68 | 1.86 | after listing | 27 May 2025 |
| FY2025 | 103.84 | – | 16.27 | 8.12 | after listing | 27 May 2025 |
Promoter Holding
Promoter holding has moved from 70.17% on 31 December 2025 to 68.29% on 30 September 2026 (-1.88 percentage points).
| As of | Promoters | Public |
|---|---|---|
| 30 September 2026 | 68.29% | 31.71% |
| 30 June 2026 | 68.29% | 31.71% |
| 31 March 2026 | 68.29% | 31.71% |
| 31 December 2025 | 70.17% | 29.83% |
Sources: BSE filings (results XBRL, shareholding pattern, board meetings), BSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.